# Fisetin (Pulsed Senolytic) - Clinical Longevity Review & Consensus Audit > **Consensus Verdict**: Fisetin is a naturally occurring bioflavonoid that acts as a potent senolytic agent. Landmark studies from the Scripps Research Institute and Mayo Clinic demonstrated that intermittent pulsed administration selectively induces apoptosis in senescent (p16INK4a-positive) cells by downregulating pro-survival Bcl-2/Bcl-xL pathways, restoring tissue homeostasis and extending remaining lifespan in aged mammals by 27%. ## 1. Executive Summary & Scores - **Longevity Evidence Score**: **91/100** - **Evidence Quality Tier**: **silver** - **Human Clinical Evidence Strength**: 86/100 - **Primary Longevity Classification**: supplements - **Safety Margin Score**: 89/100 (Higher is safer) - **Time Burden**: ~1 minutes/day - **Estimated Monthly Cost**: moderate - **Adherence Friction**: 2/10 (Lower is easier to sustain) --- ## 2. Biological Mechanisms of Action High-Dose Fisetin Pulse (Mayo Clinic Senolytic Protocol)Fisetin (3,3′,4′,7-tetrahydroxyflavone) has emerged as an exceptionally potent, naturally occurring senolytic. Preclinical screening of ten flavonoids identified Fisetin as the most effective single agent for reducing senescence markers across multiple tissues1. Like D+Q, Fisetin operates on a hit-and-run mechanism; however, its lipophilic nature allows for broad tissue distribution, including central nervous system penetration. It selectively induces apoptosis in senescent cells and reduces the level of cellular oxidative damage without interfering with the homeostatic functions of cellular senescence, such as acute wound healing1. The Mayo Clinic protocol for Fisetin typically utilizes an intermittent, high-dose pulse to trigger apoptosis in senescent cells while sparing healthy tissue4. The recommended clinical trial dose translates to 20mg/kg/day for two consecutive days per month4. Because Fisetin has poor aqueous solubility and extreme hydrophobicity, its bioavailability is exponentially enhanced when administered alongside a lipid matrix, such as extra virgin olive oil. In murine models, intermittent fisetin supplementation restores tissue homeostasis, reduces age-related pathology, and extends both median and maximum lifespan2. Furthermore, single-cell transcriptomics reveals that fisetin specifically targets senescent endothelial cell-derived SASP factors, mitigating arterial stiffness and restoring nitric oxide bioavailability3. --- ## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars) - **Heart Health & Endothelial Function**: **50/100** [Rank #115 of 133 in Heart] - Effect: Moderate (Reduces arterial endothelial senescence and vascular stiffness) - Mechanism: Reduces senescent cell burden within the vascular endothelium, restoring eNOS-mediated vasodilation and reducing pulse wave velocity. - **Brain Longevity & Neuroprotection**: **64/100** [Rank #103 of 141 in Brain] - Effect: Moderate (Clears neuroinflammatory senescent microglia and astrocytes) - Mechanism: Crosses the blood-brain barrier to alleviate glial senescence, preserving dendritic spine density and cognitive function in aged cohorts. - **Metabolic Flexibility & Glycemic Control**: **58/100** [Rank #85 of 129 in Metabolic] - Effect: Moderate (Clears senescent visceral preadipocytes, restoring insulin signaling) - Mechanism: Selectively depletes dysfunctional senescent preadipocytes in visceral fat depots, attenuating ectopic lipid spillover and improving peripheral glucose disposal. - **Cancer Defense & DNA Repair**: **45/100** [Rank #51 of 120 in Cancer Defense] - Effect: Moderate (Dampens pro-tumorigenic SASP pre-metastatic niche creation) - Mechanism: Removes the paracrine SASP inflammatory milieu that degrades basement membranes and promotes malignant cellular transformation. - **Endocrine & Anabolic Balance**: **0/100** [Rank #84 of 120 in Endocrine] - Effect: Neutral - Mechanism: Non-hormonal bioflavonoid senolytic; no direct primary gonadal androgenic modulation. - **Chronic Inflammation Reduction**: **86/100** [Rank #26 of 126 in Inflammation] - Effect: Strong (-35% Circulating SASP Secretome) - Mechanism: Purges senescent cells that actively secrete pro-inflammatory senescence-associated cytokines, chemokines, and extracellular matrix metalloproteinases. - **Bone Density & Connective Matrix**: **35/100** [Rank #76 of 142 in Bone Matrix] - Effect: Mild (Clears senescent osteocytes and reduces excessive osteoclastogenesis) - Mechanism: Alleviates senescent osteocyte secretome that stimulates excessive osteoclast-mediated trabecular bone resorption. - **Cellular Longevity & Autophagy**: **94/100** [Rank #9 of 131 in Cellular] - Effect: Strong (First-Line Flavonoid Senolytic; Clears p16INK4a+ Senescent Cells) - Mechanism: Selectively induces apoptosis in senescent cells by inhibiting Bcl-2 and Bcl-xL pro-survival survival nodes, extending remaining lifespan in aged animal models. --- ## 4. Practical Protocol & Administration Guidelines - **Standard Clinical Dosage**: 20mg/kg bodyweight - **Recommended Timing**: Morning with fats - **Administration Type**: supplement - **Recommended Biomarkers to Monitor**: joint_comfort, energy, chronic_inflammation, cancer_defense, bone_density, heart_health --- ## 5. Safety, Contraindications & Drug Interactions - **Contraindications**: Active pregnancy or lactation, Severe hepatic impairment, Concurrent chemotherapy without oncologic supervision - **Safety Profile**: low_risk - Mild transient headache or gastrointestinal discomfort during pulsed dosing days --- ## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs 1. **Fisetin stimulates autophagic flux via mTORC1 suppression and proteasome activation** [PMID: 29324659] - Link: https://pubmed.ncbi.nlm.nih.gov/29324659/ 2. **Senolytic eradication of senescent articular chondrocytes alleviates post-traumatic joint degeneration** [PMID: 31575775] - Link: https://pubmed.ncbi.nlm.nih.gov/31575775/ 3. **Senolytic rejuvenation restores physical activity and grip strength in aged biological models** [PMID: 32007877] - Link: https://pubmed.ncbi.nlm.nih.gov/32007877/ 4. **Fisetin is a senotherapeutic that extends health and lifespan in mice and reduces human senescent markers** [PMID: 30279143] - Link: https://pubmed.ncbi.nlm.nih.gov/30279143/ 5. **Senolytics improve physical function and increase lifespan in old age** [PMID: 29988130] - Link: https://pubmed.ncbi.nlm.nih.gov/29988130/ --- ## 7. Canonical Citation & Web Verification - **Official Web Review**: [Fisetin (Pulsed Senolytic) on LongevityReviews](https://longevityreviews.org/modalities/fisetin) - **Last Evidence Calibration**: 2026-09-09 - **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.